<div id="readability-page-1"><p>In a report released today, Susannah Ludwig from Bernstein maintained a Sell rating on Gerresheimer, with a price target of <span id="expert-recommendation-target">€25.68</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Ludwig covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Gerresheimer, and Sartorius Stedim Biotech. According to TipRanks, Ludwig has an average return of <span>-7.5%</span> and a 24.39% success rate on recommended stocks. </p> <p>The word on The Street in general, suggests a Hold analyst consensus rating for Gerresheimer with a €31.32 average price target.</p></div>

<p>Bernstein's Susannah Ludwig maintains a Sell rating for Gerresheimer with a €25.68 price target. Ludwig, who covers the Healthcare sector, has an average return of -7.5% and a 24.39% success rate. The general analyst consensus suggests a Hold rating with a €31.32 average price target for Gerresheimer.</p>

Bernstein Sticks to Their Sell Rating for Gerresheimer (0NTI)